Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 21.62
-2.78 (-11.39%)
At close: Feb 2, 2026
Frontier Biotechnologies Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -167.73 | -201.38 | -328.96 | -356.76 | -260.06 | -230.73 |
Depreciation & Amortization | 22.59 | 22.59 | 45.36 | 51.28 | 44.04 | 38.19 |
Other Amortization | 19.63 | 19.63 | 1.37 | 1.3 | 1.18 | 1.26 |
Loss (Gain) From Sale of Assets | -0.02 | -0.02 | 3.08 | 0 | -0 | - |
Asset Writedown & Restructuring Costs | 36.7 | 36.7 | 3.22 | 0.01 | - | 0 |
Loss (Gain) From Sale of Investments | -84.18 | -84.18 | -16.66 | -19.94 | -38.01 | -5.7 |
Provision & Write-off of Bad Debts | -2.21 | -2.21 | 0.41 | 1.6 | 1.22 | 0.4 |
Other Operating Activities | -28.14 | 23.38 | 9.2 | 7.27 | -7.19 | 0.93 |
Change in Accounts Receivable | 38.6 | 38.6 | 2.43 | -58.03 | 5.73 | -27.68 |
Change in Inventory | 9.49 | 9.49 | -3.39 | -17.37 | -21.97 | 1.48 |
Change in Accounts Payable | -35.11 | -35.11 | 16.56 | 99.38 | 24.83 | 31.61 |
Change in Other Net Operating Assets | - | - | 0.22 | 2.24 | 7.16 | 20.05 |
Operating Cash Flow | -190.38 | -172.52 | -267.17 | -289.04 | -243.07 | -170.17 |
Capital Expenditures | -27.73 | -18.6 | -129.35 | -140.37 | -327.15 | -186.41 |
Sale of Property, Plant & Equipment | 0.03 | 0.03 | 0.24 | 0 | 0.16 | - |
Divestitures | 53.79 | 48.66 | - | - | - | - |
Investment in Securities | -236.49 | -236.49 | 284 | -1 | 271 | -784 |
Other Investing Activities | 443.63 | 15.62 | 17.81 | 24.11 | 37.73 | 5.13 |
Investing Cash Flow | 233.23 | -190.78 | 172.7 | -117.27 | -18.26 | -965.28 |
Long-Term Debt Issued | - | 393.93 | 312.8 | 202.57 | 279.69 | 14.99 |
Long-Term Debt Repaid | - | -287.7 | -216.64 | -220.84 | -32 | -19.13 |
Net Debt Issued (Repaid) | 7.45 | 106.23 | 96.16 | -18.27 | 247.68 | -4.14 |
Issuance of Common Stock | - | - | - | 195.67 | - | 1,751 |
Common Dividends Paid | -8.62 | -14.91 | -14.46 | -15.13 | -5.54 | -1.36 |
Other Financing Activities | -18.26 | -5.7 | -11.41 | -2.8 | -22.82 | 2.2 |
Financing Cash Flow | -19.42 | 85.61 | 70.29 | 159.46 | 219.32 | 1,748 |
Foreign Exchange Rate Adjustments | -0.03 | 0 | -0.05 | 0.16 | 0.23 | -0.48 |
Net Cash Flow | 23.4 | -277.68 | -24.23 | -246.68 | -41.78 | 611.7 |
Free Cash Flow | -218.11 | -191.12 | -396.52 | -429.42 | -570.22 | -356.59 |
Free Cash Flow Margin | -154.47% | -147.61% | -347.07% | -506.74% | -1407.84% | -764.83% |
Free Cash Flow Per Share | -0.58 | -0.51 | -1.06 | -1.18 | -1.58 | -1.24 |
Cash Income Tax Paid | 3.55 | 4.21 | -6.39 | -54.05 | -12.26 | 1.13 |
Levered Free Cash Flow | -176.51 | -371.35 | -343.6 | -403.69 | -482.68 | -273.77 |
Unlevered Free Cash Flow | -170.72 | -364.88 | -338.31 | -400.72 | -481.72 | -272.92 |
Change in Working Capital | 12.98 | 12.98 | 15.81 | 26.21 | 15.75 | 25.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.